Skip to main content
Edmund Huang, MD, Nephrology, West Hollywood, CA

EdmundHuangMD

Nephrology West Hollywood, CA

Assistant Professor, Medicine, University of California Los Angeles David Geffen SOM

Dr. Huang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Huang's full profile

Already have an account?

  • Office

    Cedarssinai Comprehensive Transplant Center
    8900 Beverly Boulevard 2ND floor
    West Hollywood, CA 90048
    Phone+1 310-248-6528
    Fax+1 310-423-4678

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 2004 - 2006
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2001 - 2004
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2026
  • MD State Medical License
    MD State Medical License 2007 - 2010
  • IL State Medical License
    IL State Medical License 1995 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Regulatory Press Release: Hansa Biopharma Interim Report January–June 2019
    Regulatory Press Release: Hansa Biopharma Interim Report January–June 2019July 18th, 2019
  • Plenary Presentation at the 2019 American Transplant Congress Demonstrates Significant Reduction in Time on the Waitlist for Patients Treated with Imlifidase Compared to Matched Controls
    Plenary Presentation at the 2019 American Transplant Congress Demonstrates Significant Reduction in Time on the Waitlist for Patients Treated with Imlifidase Compared to Matched ControlsJune 7th, 2019
  • Study Raises Questions About U.S. Kidney Allocation System
    Study Raises Questions About U.S. Kidney Allocation SystemApril 12th, 2019
  • Join now to see all